FDA Officials Say Industrial Hemp and CBD Regulatory Plans Are Months Away from Implementation

With the Food and Drug Administration (FDA) conducting a scientific review of hemp, senior officials at the agency say they are months away from releasing regulatory assessments for industrial hemp-based products such as CBD. In recent years, the FDA has been heavily criticized for its lack of rules to allow the sale of hemp in the food supply or as a dietary supplement. Industrial hemp and its derivatives were federally legalized under the 2018 Farm Bill, but the agency has long argued that more research must be conducted before regulations on consumer cannabinoid products are finalized, or Congress should step in again.

Information source: new.qq.com/omn/author/8713560